10-Q: Bio Essence Corp. Reports Net Income of $223,752 for Q1 2024 Following Discontinued Operations

Bio Essence Corp. announces a net income of $223,752 for the quarter ended March 31, 2024, primarily driven by gains from the disposal of discontinued operations, despite ongoing concerns about the company's ability to continue as a going concern.

Summary

• Bio Essence Corp. reported a net income of $223,752 for the three months ended March 31, 2024, compared to a net loss of $178,836 for the same period in 2023.
• The company's net income includes a gain of $256,925 from discontinued operations.
• Revenues from continuing operations were $0 for both the three months ended March 31, 2024 and 2023.
• The company's general and administrative expenses from continuing operations increased by $37,705 to $62,015 for the three months ended March 31, 2024.
• The company had an accumulated deficit of $8,916,722 from continuing operations as of March 31, 2024, raising substantial doubt about its ability to continue as a going concern.
• Management intends to increase income by strengthening its sales force, providing attractive sales incentive programs, and increasing marketing and promotion activities.
• Management also intends to raise additional funds through a private or public offering, or by obtaining loans.
• The company sold its subsidiaries BEP and BEH in December 2023 and March 2024, respectively, and dissolved McBE in April 2024.
• As of March 31, 2024, the company's current liabilities exceeded current assets, resulting in a working capital deficit of $1,433,741.
• The company's principal source of funds is loans from an officer who is also a major shareholder.
• The company believes it will need $1.2 million in cash to continue its current business for the next 12 months.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the company's lack of revenue from continuing operations, accumulated deficit, and uncertainty about its ability to continue as a going concern. While the net income for the quarter is positive, it is primarily driven by gains from discontinued operations, which is not a sustainable source of revenue.

Positives

• The company achieved a net income of $223,752 for the quarter, a significant improvement compared to the net loss in the same period last year.
• Gains from the disposal of subsidiaries BEP and BEH contributed significantly to the net income.
• The company is actively seeking additional funding to support its operations and address its working capital deficit.

Negatives

• The company's continuing operations had no revenue for the quarter.
• The company has a significant accumulated deficit of $8,916,722 from continuing operations.
• The company's current liabilities exceed its current assets, resulting in a working capital deficit.
• The company's ability to continue as a going concern is uncertain.

Risks

• The company's ability to secure additional funding is uncertain.
• The company's reliance on loans from a major shareholder poses a risk.
• The company's lack of revenue from continuing operations is a significant concern.
• The company's accumulated deficit and working capital deficit could hinder its ability to operate effectively.

Future Outlook

Management intends to increase income by strengthening its sales force, providing attractive sales incentive programs, and increasing marketing and promotion activities. Management also intends to raise additional funds by way of a private or public offering, or by obtaining loans from banks or others. The company believes it will need $1.2 million in cash to continue its current business for the next 12 months.

Management Comments

• Management plans to increase its income by strengthening its sales force, providing attractive sales incentive program, and increasing marketing and promotion activities.
• Management also intends to raise additional funds by way of a private or public offering, or by obtaining loans from banks or others.
• The company believes it will need $1.2 million cash to continue our current business for the next 12 months.

Industry Context

The health supplement industry is competitive, and Bio Essence Corp.'s performance is affected by factors such as consumer preferences, regulatory changes, and economic conditions. The company's shift towards discontinued operations and focus on securing additional funding reflects a strategic adjustment to navigate these challenges.

Comparison to Industry Standards

• It is difficult to compare Bio Essence Corp.'s results to industry standards without knowing the specific segment of the health supplement market in which it operates.
• However, the company's lack of revenue from continuing operations and its reliance on discontinued operations for profitability are concerning compared to industry peers.
• Companies like Herbalife Nutrition and Amway, which operate in the health and wellness sector, typically have diversified revenue streams and strong brand recognition.
• Bio Essence Corp.'s need for additional funding and its going concern uncertainty also raise concerns compared to more financially stable companies in the industry.

Related Party Transactions

• The Company had loans from one major shareholder (also the Company's senior officer) for $1,370,746 and $1,180,046 at March 31, 2024 and December 31, 2023, respectively.
• The Company had a loan from another major shareholder for $608,631 for settling the litigation.
• On May 31, 2023, the Board of Directors of Bio Essence Corp. approved a debt-to-equity conversion where Ms. Yan received 5,000,000 shares of the Company's common stock in exchange for retirement of the $2,500,000 debt.

Stakeholder Impact

• Shareholders face uncertainty due to the company's going concern issues and potential dilution from future equity offerings.
• Employees may be affected by potential cost-cutting measures or restructuring efforts.
• Customers may experience changes in product availability or service quality due to the company's financial challenges.
• Suppliers and creditors face increased risk of non-payment due to the company's liquidity issues.

Next Steps

• The company plans to strengthen its sales force, provide attractive sales incentive programs, and increase marketing and promotion activities.
• The company intends to raise additional funds through a private or public offering, or by obtaining loans from banks or others.

Key Dates

Keywords

financial results, discontinued operations, going concern, net income, subsidiary sale, Bio Essence Corp, funding, deficit